OncoCyte Corporation (OCX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 86.55M |
| Enterprise Value | 78.47M |
| P/E Ratio | -3.55 |
| PEG Ratio | -0.04 |
| Price/Sales Ratio | 74.02 |
| Price/Book Ratio | -17.35 |
| Enterprise/Revenue | 61.13 |
| Enterprise/EBITDA | -2.62 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -24.55 |
| Operating Margin | -21.12 |
| Return On Assets | -1.18 |
| Return On Equity | 3.81 |
| Revenue | 4.06M |
| Revenue/Share | 0.06 |
| Gross Profit | 2.3M |
| EBITDA | 2.2M |
| Net Income | -50.22M |
| Diluted EPS | -1.65 |
| Total Cash | 28.2M |
| Total Cash/Share | 0.82 |
| Total Debt | 3.07M |
| Total Debt/Equity | -0.29 |
| Current Ratio | 2.54 |
| Book Value Per Share | -0.31 |
| 52-Week Change | -3.03 |
| 52-Week High | 4.75 |
| 52-Week Low | 1.92 |
| Moving Average 50 Days | 3.03 |
| Moving Average 200 Days | 2.8 |
| Average Volume | 76,061 |
| Shares Outstanding | 28.6M |
| % Held by Institutions | 0.17 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | July 25, 2023 |